ICU Medical Inc
ICU Medical Inc (ICUI) Covered Calls
As of September 25, 2026, ICUI has 30 covered call opportunities in the coming three months. Return ranges from 3.4 to 40.6% until expiration. Annualized return ranges from 22.2 to 192.7%. The nearest expiration is October 16, 2026. Maximum potential profit is $6,748.
Read more
Running ICUI covered calls helps you generate consistent income from ICU Medical Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on ICU Medical Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best ICUI covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if ICUI stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling ICUI covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given ICU Medical Inc covered call is worth writing.
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs.
It also provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. The company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. It also provides critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.
Income-focused investors, long-term ICUI holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling ICUI covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best ICU Medical Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryMedical Instruments & Supplies
- SectorHealthcare
- IV percentile60.32% Neutral
- Market cap (M$)4,125
- 52 weeks high-14.47%
- 52 weeks low46.62%
- Analyst recommendationStrong Buy
1.25 - Target price$195.57
18.56% above the current stock price - Dividend—
- Payout ratio0.00%
- Earnings date2026-11-05
- P/E139.34
- Future P/E17.06
- EPS (ttm)1.18
- EPS growth next 5 years10.24%
As of September 25, 2026
| 2026-10-16 | 22 | 185.00 | 11.43 | 0.30 | 1.00 | 1928.00 | 11.61 | 192.67 | -0.18 | +0.10 | 0 | 0.70 |
| 2026-11-20 | 57 | 200.00 | 20.47 | 0.05 | 3.70 | 3403.00 | 20.50 | 131.26 | -0.03 | +0.15 | 0 | 3.65 |
| 2026-11-20 | 57 | 195.00 | 17.46 | 0.20 | 4.50 | 2918.00 | 17.58 | 112.55 | -0.12 | +0.18 | 0 | 4.30 |
| 2026-11-20 | 57 | 190.00 | 14.44 | 1.30 | 5.50 | 2528.00 | 15.23 | 97.51 | -0.78 | +0.24 | 8 | 4.20 |
| 2027-02-19 | 148 | 230.00 | 38.54 | 0.15 | 3.90 | 6413.00 | 38.63 | 95.26 | -0.09 | +0.12 | 3 | 3.75 |
| 2026-10-16 | 22 | 175.00 | 5.41 | 0.05 | 4.30 | 903.00 | 5.44 | 90.24 | -0.03 | +0.28 | 2 | 4.25 |
| 2026-11-20 | 57 | 185.00 | 11.43 | 2.40 | 6.50 | 2138.00 | 12.88 | 82.46 | -1.45 | +0.29 | 0 | 4.10 |
| 2027-02-19 | 148 | 220.00 | 32.51 | 0.80 | 4.90 | 5478.00 | 33.00 | 81.38 | -0.48 | +0.16 | 0 | 4.10 |
| 2027-02-19 | 148 | 210.00 | 26.49 | 2.40 | 6.60 | 4638.00 | 27.94 | 68.90 | -1.45 | +0.22 | 0 | 4.20 |
| 2026-11-20 | 57 | 180.00 | 8.42 | 3.80 | 8.00 | 1778.00 | 10.71 | 68.58 | -2.29 | +0.35 | 0 | 4.20 |
As of September 25, 2026
Sell covered calls with the data behind you
Find the best ICUI covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→